Panagora Asset Management’s Aratana Therapeutics, Inc. PETX Stock Holding History

Panagora Asset Management’s Portfolio PETX Stock Details PETX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-4,195	Closed	-$22K	–	2797
2019 Q2	$22K	Buy	+4,195	New	+$18.9K	﹤0.01%	2267
2019 Q1	–	Sell	-129	Closed	-$1K	–	2633
2018 Q4	$1K	Sell	129 -20,461	-99%	-$125K	﹤0.01%	2440
2018 Q3	$120K	Sell	20,590 -40,466	-66%	-$202K	﹤0.01%	1807
2018 Q2	$259K	Sell	61,056 -16,694	-21%	-$84.2K	﹤0.01%	1572
2018 Q1	$343K	Buy	77,750 +67,987	+696%	+$303K	﹤0.01%	1501
2017 Q4	$51K	Buy	+9,763	New	+$59.7K	﹤0.01%	2049
2016 Q1	–	Sell	-6,350	Closed	-$35K	–	2374
2015 Q4	$35K	Buy	6,350 +4,862	+327%	+$32.1K	﹤0.01%	2070
2015 Q3	$13K	Buy	+1,488	New	+$25.2K	﹤0.01%	2201

Other funds holding PETX

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Panagora Asset Management's PETX Position: Q3 2019 in Review

Panagora Asset Management sold out of Aratana Therapeutics, Inc. (PETX) in Q3 2019, closing a stake of 4,195 shares — an estimated $22K sold.

Panagora Asset Management first reported a position in PETX in Q3 2015 and held it in 8 quarters. The position peaked at $343K in Q1 2018. 2 funds tracked by Wall St. Rank hold PETX as of Q3 2019.

Panagora Asset Management reported no remaining Aratana Therapeutics, Inc. position as of Q3 2019 after selling out during the quarter.
Panagora Asset Management sold 4,195 Aratana Therapeutics, Inc. shares in Q3 2019, an estimated $22K.
Panagora Asset Management first reported a position in Aratana Therapeutics, Inc. in Q3 2015 and held it in 8 quarters.
Panagora Asset Management's Aratana Therapeutics, Inc. position peaked at $343K in Q1 2018.
2 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q3 2019.

Based on Panagora Asset Management's 13F filing for Q3 2019, filed 12 Nov 2019.